Smoke-free
Product Platforms
We believe reducing harm for adult smokers can only be successful if these consumers find potentially reduced-risk products “satisfying” – a term with a wide-ranging definition based on the diversity of adult smokers’ interests.
Our goal is to provide adult smokers with a variety of satisfying smoke-free options and guide them responsibly towards these alternatives.
Our companies focus on developing, manufacturing and marketing products and brands that meet three important consumer expectations:
- superior sensory experiences and nicotine satisfaction;
- reduced health risks and accurate relative risk information; and
- the ability to avoid social friction associated with cigarettes, such as smoke odor, ash and social isolation.
Over decades, we have built a deep understanding of adult tobacco consumers, the role tobacco products play in their lives, and why they choose specific products and brands. Recently we:
- conducted research with approximately 50,000 consumers;
- analyzed more than four billion consumer transactions at retail; and
- engaged with consumers millions of times with our brands.
Science and research are critical to developing innovative smoke-free products and gathering scientific data for Food & Drug Administration (FDA) product applications. We're developing products backed by rigorous science and evidence to support FDA authorization.
Smoke-free Product Platforms
Our portfolio approach expands choice for adult tobacco consumers across three of the most promising smoke-free product platforms with the potential to reduce harm: oral tobacco, e-vapor and heated tobacco. These include:
Oral Tobacco – Smokeless Tobacco
U.S. Smokeless Tobacco Company is the most profitable moist smokeless tobacco (MST) company, anchored by Copenhagen®, the leading MST brand, Skoal®, Red Seal® and Husky®.
Oral Tobacco – Nicotine Pouches
on!® has a premium portfolio of product offerings across a variety of flavors and nicotine strengths.
on! PLUS® is a spit-free nicotine pouch product that uses our proprietary “soft-feel” material. It's currently in limited distribution in Sweden and the UK, and we plan to submit to the FDA a Premarket Tobacco Application.
E-Vapor
On June 1, 2023, Altria completed its acquisition of NJOY Holdings, Inc. NJOY’s product portfolio includes NJOY ACE®* and NJOY DAILY®, the first e-vapor products to receive market authorizations from the FDA for both tobacco and menthol variants. Currently, NJOY is the only FDA authorized menthol e-vapor product. Read Press Release
Heated Tobacco Products
We have a majority-owned joint venture with JT Group, called Horizon Innovations, for the U.S. marketing and commercialization of heated tobacco stick products. We’re working toward a PMTA submission for Ploom® through our partnership with JT Group, and we’re separately continuing internal development of SWIC®, an innovative heated tobacco capsule product.
Did you Know?
92% of health care professionals;89% of policy professionals;
79% of adult cigarette smokers 21+; and
78% of general population adult 21+
surveyed say it is important for the FDA to focus on making smoke-free tobacco products available to adults who can’t or won’t quit smoking to help them switch from cigarettes, the most harmful form of tobacco, and
98% of health care professionals;
93% of policy professionals;
89% of general population adults 21+; and
89% of adult cigarette smokers 21+
surveyed agree that the FDA has a responsibility to accurately inform adults who use tobacco about the different levels of harm associated with different tobacco products.1
You May Also Like
